PET/CT imaging of clear cell renal cell carcinoma with 124I labeled chimeric antibody

PET/CT imaging of clear cell renal cell carcinoma with 124I labeled chimeric antibody

Clear cell renal cell carcinoma (ccRCC) presents problems for urologists in diagnosis, treatment selection, intraoperative surgical margin analysis, and long term monitoring. In this paper we describe the development of a radiolabeled antibody specific to ccRCC (124I-cG250) and its potential to help...

Full description

Bibliographic Details
Main Authors: Eamonn E. Bahnson, Douglas A. Murrey, Cathy M. Mojzisik, Nathan C. Hall, Humberto J. Martinez-Suarez, Michael V. Knopp, Edward W. Martin, Stephen P. Povoski, Robert R. Bahnson
Format: Article
Language:English
Published: SAGE Publishing 2009-06-01
Series:Therapeutic Advances in Urology
Online Access:https://doi.org/10.1177/1756287209105264

Internet

https://doi.org/10.1177/1756287209105264

Similar Items